BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Bayer AG Loses Battle To Block Generic Cancer Drug In India's Top Court     12/15/2014
Oncothyreon Inc. Strikes $300 Million Cancer Pact With Array BioPharma, Inc.     12/15/2014
Pfizer Grabs Rights To Preclinical Drugs From Startup In $29 Million+ Deal     12/9/2014
Evgen Pharma Will Float £20M IPO To Fund Cancer Drug Trials     12/4/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Exelixis, Inc. COMET-2 Ph3 Cabozantinib Trial Fails To Meet Primary Endpoint     12/2/2014
Dynavax Technologies Corporation Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline     12/1/2014
Genentech Defends Supply Shift For Top Cancer Drugs     11/26/2014
Cell Medica Rakes In $78 Million Series B To Advance Cancer Program     11/25/2014
GlaxoSmithKline Shareholders To Vote On Novartis AG Deal On Dec. 18     11/24/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme, Says Citi     11/21/2014
AstraZeneca PLC Shows Off Strong Drug Pipeline As Pfizer Deadline Looms     11/18/2014
Pfizer, Merck KGaA Strike A $2.9B Deal To Develop Cancer Tumor Treatment     11/18/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
Merck & Co. Announces Positive Study Investigating The Use Of KEYTRUDA® (pembrolizumab) Compared To Chemotherapy In Patients With Ipilimumab-Refractory Advanced Melanoma     11/17/2014
 Featured Stories
Testosterone Linked To Colon Cancer Growth, University of Missouri Study     12/16/2014
Low-Fat Diet May Help Women Survive Breast Cancer, UCLA Medical Center Study     12/16/2014
Man Talks About How Killer T-Cells Eradicated His Cancer     12/15/2014
What "60 Minutes" Didn't Tell You About The Billionaire Who Is Trying To Disrupt Cancer Care     12/10/2014
No Link Found Between Bladder Cancer And Popular Diabetes Meds, University of Dundee Study     12/8/2014
How Red Wine Prevents Cancer, University of Colorado Study     12/5/2014
Gotta Get That Rhythm: Virginia Tech Researchers Find A Relationship Between Sleep Cycle, Cancer Incidence     12/4/2014
A*STAR Scientists Uncover Gene Associated With An Aggressive Breast Cancer     12/2/2014
Vegetable Oil Ingredient Key To Destroying Gastric Disease Bacteria, University of California, San Diego (UCSD) Study     12/1/2014
Selenium Compounds Boost Immune System To Fight Against Cancer, University of Copenhagen Study     12/1/2014
The Dirty Side Of Soap, University of California, San Diego (UCSD) Study     11/19/2014
Walnuts Slow Prostate Cancer In Mice, University of California, Davis (UCD) Study     11/18/2014
University of North Carolina Researchers Silence Leading Cancer-Causing Gene     11/18/2014
Lactose Intolerants Linked To Lower Cancer Risk, Lund University Study     11/6/2014
Long Term Shift Work Linked To Impaired Brain Function, Occupational & Environmental Medicine Reveals     11/5/2014
 More News
St. Jude Children's Research Hospital Release: Cells Identified That Enhance Tumor Growth And Suppress Anti-Cancer Immune Attack     12/19/2014
Hutchison Medipharma Starts Phase III Trial Of Cancer Drug     12/18/2014
Curis, Inc. (CRIS) Announces Dosing Of First Patient In Phase 1 Trial Of CUDC-907 In Patients With Advanced/ Relapsed Solid Tumors     12/18/2014
Stemline Therapeutics, Inc. (STML) Initiates SL-401 Clinical Trial In Four Rare Myeloproliferative Neoplasms     12/17/2014
HedgePath Pharmaceuticals Receives IND Clearance To Commence Development Of Its Proposed Cancer Treatment     12/16/2014
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs     12/16/2014
NewGen Therapeutics Targeted Anti-Cancer Drug, NT-113, Demonstrates Compelling Activity In Glioblastoma Xenograft Models     12/16/2014
Astellas Pharma Inc. (ALPMY) Release: Data Presented From Phase 2 Study Of Enzalutamide In Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer     12/15/2014
Advaxis, Inc. Announces FDA Acceptance Of Its Investigational New Drug Application To Commence Clinical Trials Of ADXS-HPV In Combination With MedImmune (AZN)'s MEDI4736 For The Treatment Of HPV-Associated Cancers     12/15/2014
BeyondSpring To Start China-U.S. Phase 3 Trial Of Novel Cancer Drug     12/12/2014
MD Anderson Cancer Center Officials React To FDA Approval Of Gardasil 9 For The Prevention Of Certain Cancers     12/12/2014
Atterocor Expands Phase 1 Trial Of ATR-101 To Additional Leading Adrenal Cancer Centers     12/11/2014
Enzyme Bio-Systems Ltd. Release: Preclinical Xenograft Studies Show Positive Results For Amooranin     12/11/2014
Syros Pharmaceuticals Announces New Research Published On CDK7 In Lung And Pediatric Cancers     12/11/2014
RedHill Biopharma Ltd. (RDHL) Submits BEKINDA™ (RHB-102) European Marketing Authorization Application For Oncology Support     12/9/2014